drugset / Trial / NCT04814368
A Safety and Efficacy Study of Anti-inflammatory (Canakinumab) and Cartilage Stimulating (LNA043) Drugs Injected Into the Knee Joint of Participants With Knee Osteoarthritis (OA)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study was established to show safety and efficacy of canakinumab and LNA043 in patients with knee osteoarthritis (OA).
Timeline
- Start
- 2021-08-27
- Primary completion
- 2024-06-24
- Completion
- 2024-06-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Canakinumab | Monoclonal antibody | 600 mg | Other |
| Subject | LNA043 | Unknown | 40 mg | Other |